Showing results (501-510 of 523) with videos related to
Sort By:
Pageof 53
Biorxiv : the Preprint Server for Biology|February 23, 2021
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19Carly G K Ziegler, Vincent N Miao, Anna H Owings, et al.Microbiology Spectrum|April 30, 2024
An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfectionCarly G K Ziegler, Anna H Owings, Michelle Galeas-Pena, et al.Radiology. Imaging Cancer|August 18, 2020
Hyperpolarized 13C MRI of Tumor Metabolism Demonstrates Early Metabolic Response to Neoadjuvant Chemotherapy in Breast CancerRamona Woitek, Mary A McLean, Andrew B Gill, et al.The Lancet. Oncology|May 9, 2017
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trialHelena M Earl, Louise Hiller, Helen C Howard, et al.Cancer Cell|June 27, 2025
Gene context drift identifies drug targets to mitigate cancer treatment resistanceAmir Jassim, Birgit V Nimmervoll, Sabrina Terranova, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 19, 2024
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: TreatmentC C Zouboulis, F G Bechara, F Benhadou, et al.Diabetes Care|April 22, 2018
Gaps in Guidelines for the Management of Diabetes in Low- and Middle-Income Versus High-Income Countries-A Systematic ReviewMayowa O Owolabi, Joseph O Yaria, Meena Daivadanam, et al.Lancet (London, England)|June 11, 2019
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trialHelena M Earl, Louise Hiller, Anne-Laure Vallier, et al.The New Phytologist|July 25, 2023
Expression quantitative trait loci mapping identified PtrXB38 as a key hub gene in adventitious root development in PopulusTao Yao, Jin Zhang, Timothy B Yates, et al.Science Translational Medicine|June 20, 2020
ctDNA monitoring using patient-specific sequencing and integration of variant readsJonathan C M Wan, Katrin Heider, Davina Gale, et al.Pageof 53